CSI Pharmacy has become the first multi-location specialty pharmacy to achieve the Distinction in Immunoglobulin (Ig) Therapy, a prestigious accreditation jointly created by the Accreditation ...
AOM Infusion (“AOM”), a leading provider of specialty infusion care and pharmacy services, announced today that it has earned the Distinction in Immunoglobulin (Ig) Therapy from the Accreditation ...
Business Wire: Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1
Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1
EurekAlert!: Antibodies targeting immunoglobulin E Cε2 region as potential rapid anti-allergy therapy
Morningstar: Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1
Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1 − GAMMAGARD LIQUID ERC [immune globulin ...
Benzinga.com: Strong Immunoglobulin Reduction Data Positions Biohaven's BHV-1300 As Potential Autoimmune Therapy
Plasma-derived immunoglobulin replacement therapy (IRT) is one of the mainstays of supportive management for many inborn errors of immunity, primarily those affecting the adaptive immune system which ...
Immunoglobulin replacement therapy in CLL patients does not reduce serious infection risk, despite increased usage over 14 years. The study found higher infection rates during immunoglobulin therapy ...
EurekAlert!: Immunoglobulin replacement therapy shows no reduction in serious infections for patients with CLL
(WASHINGTON, ) — In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious ...